Claire M Payne

Author PubWeight™ 40.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res 2002 2.13
2 Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol 2011 1.92
3 Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 2002 1.75
4 Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol 2009 1.63
5 Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut 2006 1.58
6 Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells. Mol Cancer Ther 2005 1.54
7 Field defects in progression to gastrointestinal tract cancers. Cancer Lett 2007 1.28
8 Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus. Clin Cancer Res 2007 1.21
9 Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis. Pediatr Res 2002 1.21
10 Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chem Biol Interact 2003 1.15
11 Long-term effects of ovarian follicular depletion in rats by 4-vinylcyclohexene diepoxide. Reprod Toxicol 2002 1.15
12 MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms. NMR Biomed 2007 1.14
13 Apoptosis resistance in Barrett's esophagus: ex vivo bioassay of live stressed tissues. Am J Gastroenterol 2005 1.13
14 Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2004 1.12
15 Increased expression and secretion of interleukin-6 in patients with Barrett's esophagus. Clin Cancer Res 2004 1.10
16 Role of polyamines in arginine-dependent colon carcinogenesis in Apc(Min) (/+) mice. Mol Carcinog 2006 1.04
17 Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis 2002 1.02
18 Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer. Genome Integr 2012 1.00
19 Identification of S-nitrosylated proteins after chronic exposure of colon epithelial cells to deoxycholate. Proteomics 2006 0.98
20 Role of mitochondrial complexes I and II, reactive oxygen species and arachidonic acid metabolism in deoxycholate-induced apoptosis. Cancer Lett 2002 0.97
21 Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cells. Mol Cancer Ther 2002 0.95
22 Assessment of apoptosis by immunohistochemical markers compared to cellular morphology in ex vivo-stressed colonic mucosa. J Histochem Cytochem 2005 0.94
23 The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis. Mol Carcinog 2006 0.94
24 A proteomic study of resistance to deoxycholate-induced apoptosis. Carcinogenesis 2004 0.90
25 Imexon activates an intrinsic apoptosis pathway in RPMI8226 myeloma cells. Anticancer Drugs 2002 0.90
26 Perils of immunohistochemistry: variability in staining specificity of commercially available COX-2 antibodies on human colon tissue. Dig Dis Sci 2003 0.89
27 alpha-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells. Cancer Immunol Immunother 2004 0.89
28 Detoxification of the polyamine analogue N1-ethyl-N11-[(cycloheptyl)methy]-4,8-diazaundecane (CHENSpm) by polyamine oxidase. Clin Cancer Res 2002 0.86
29 Deoxycholate-induced colitis is markedly attenuated in Nos2 knockout mice in association with modulation of gene expression profiles. Dig Dis Sci 2007 0.86
30 Patchy field defects of apoptosis resistance and dedifferentiation in flat mucosa of colon resections from colon cancer patients. Ann Surg Oncol 2002 0.85
31 Deoxycholate, an endogenous tumor promoter and DNA damaging agent, modulates BRCA-1 expression in apoptosis-sensitive epithelial cells: loss of BRCA-1 expression in colonic adenocarcinomas. Nutr Cancer 2003 0.84
32 Reduced Pms2 expression in non-neoplastic flat mucosa from patients with colon cancer correlates with reduced apoptosis competence. Appl Immunohistochem Mol Morphol 2006 0.83
33 Abnormal expression of biomarkers in incompletely ablated Barrett's esophagus. Ann Surg 2006 0.82
34 Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer. J Vis Exp 2010 0.82
35 Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma. Am J Gastroenterol 2009 0.80
36 A novel dietary-related model of esophagitis and Barrett's esophagus, a premalignant lesion. Nutr Cancer 2007 0.78
37 Exposure of mouse colon to dietary bile acid supplement induces sessile adenomas. Inflamm Bowel Dis 2010 0.77